---
figid: PMC8789654__fonc-11-763539-g001
figtitle: Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen
  Signaling Pathway
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC8789654
filename: fonc-11-763539-g001.jpg
figlink: /pmc/articles/PMC8789654/figure/f1/
number: F1
caption: 'The chemical structure of estrogen, estrogen metabolites and sorafenib.
  Estrogen:estrone (E1), 17-β-estradiol (Estradiol,E2), Estriol (E3), Estretrol (E4)
  and Tamoxifen; Estrogen metabolites: 2-Methoxyestradiol (2-ME); Sorafenib.'
papertitle: Anti-Hepatocellular Carcinoma Effect and Molecular Mechanism of the Estrogen
  Signaling Pathway.
reftext: Yusheng Guo, et al. Front Oncol. 2021;11:763539.
year: '2021'
doi: 10.3389/fonc.2021.763539
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: hepatocellular carcinoma (HCC) | estrogen signaling pathway | tumor therapy
  | molecular mechanism | estrogen receptor
automl_pathway: 0.5901865
figid_alias: PMC8789654__F1
figtype: Figure
redirect_from: /figures/PMC8789654__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8789654__fonc-11-763539-g001.html
  '@type': Dataset
  description: 'The chemical structure of estrogen, estrogen metabolites and sorafenib.
    Estrogen:estrone (E1), 17-β-estradiol (Estradiol,E2), Estriol (E3), Estretrol
    (E4) and Tamoxifen; Estrogen metabolites: 2-Methoxyestradiol (2-ME); Sorafenib.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Estrone
  - Tamoxifen
  - Estradiol
  - 2-Methoxyestradiol
  - Estriol
  - FOH
  - estretrol
  - Sorafenib
---
